Clinical Trials Browser

Anemia, Refractory, with Excess of Blasts × enasidenib × 1 year × Clear all

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic